Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome

L. Malcovati, M. G. Della Porta, M. Lunghi, C. Pascutto, L. Vanelli, E. Travaglino, M. Maffioli, P. Bernasconi, M. Lazzarino, R. Invernizzi, Mario Cazzola

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to develop a flow cytometric approach to the evaluation of marrow dysplasia in myelodysplastic syndromes (MDS). We first studied a cohort of 103 MDS patients as well as 46 pathological and healthy controls. Flow cytometry data were expressed as percentage of positive cells. Analysis of erythroid cells showed higher proportions of immature cells (P

Original languageEnglish
Pages (from-to)776-783
Number of pages8
JournalLeukemia
Volume19
Issue number5
DOIs
Publication statusPublished - May 2005

Keywords

  • CD34
  • CD71
  • Flow cytometry
  • Immnunophenotyping
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Fingerprint Dive into the research topics of 'Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

  • Cite this